Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Interpreting Pregnancy Risk After GLP ‐1 Receptor Agonists Discontinuation
Interpreting Pregnancy Risk After GLP ‐1 Receptor Agonists Discontinuation
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Roberta Scairati
,
Christine Newman
,
Fidelma P. Dunne
,
Annamaria Colao
Format:
Artículo Open Access
Published:
Wiley
2026
Subjects:
Diabetes, Obesity and Metabolism
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Description
DOI:
10.1111/dom.70615
Similar Items
A narrative review of metformin in pregnancy: Navigating benefit and uncertainty
by: Robert P. McEvoy, et al.
Published: (2025)
Impact of GLP ‐1 Receptor Agonist Discontinuation on Liver‐Related Parameters: A Systematic Review and Meta‐Analysis
by: Matheus Souza, et al.
Published: (2026)
Safety of GLP ‐1 and Dual GLP ‐1/ GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes
by: Lasin Ozbek, et al.
Published: (2026)
Association of GLP ‐1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program
by: Inyoung Hwang, et al.
Published: (2026)
Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP ‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes
by: Yazan Alhamdan, et al.
Published: (2026)